Menopause News

Japanese women who habitually slept 6 hours or less per night were more likely to experience menopause at an older age than those who reported longer sleep duration, according to data published in Menopause.

Three SKYLIGHT phase 3 trials demonstrated that treatment with nonhormonal fezolinetant was associated with alleviation moderate to severe vasomotor symptoms during menopause with acceptable safety and tolerability.

Women who maintained a more pro-inflammatory diet before menopause and in early perimenopause had increased risk for future fractures, according to data from the Study of Women’s Health Across the Nation.

For medicine to advance, entrenched paradigms must yield to new evidence. The widely held belief that menopausal hormone therapy causes breast cancer, and thus should never be given to breast cancer survivors, must be reassessed.

More than ever before, women today may have more information — and misinformation — about menopause.

Nearly two-thirds of midlife women reported a history of intimate partner violence, and that experience was associated with increased odds of clinical insomnia, according to a cross-sectional study published in Menopause.

For postmenopausal women, simple ovarian cysts were likely to remain unchanged or disappear during follow-up, according to a systematic review and meta-analysis published in Menopause.

The nonhormonal selective neurokinin-3 receptor antagonist fezolinetant was effective and well tolerated in treating moderate to severe vasomotor symptoms associated with menopause, according to study data.

Menopausal hormone therapy for bothersome vasomotor or other symptoms is safe and appropriate for most women at low atherosclerotic CVD risk, whereas a nuanced approach is needed for intermediate-risk women, researchers reported.

Among postmenopausal women, researchers observed no significant associations between ovarian steroids, adrenal hormones, insulin-like growth factor I, parathormone and vitamin D and handgrip strength, according to study results.